KalVista Pharmaceuticals’ Licensing Agreement with Kaken Pharmaceutical

Ropes & Gray represented KalVista Pharmaceuticals, Ltd. in the transaction. KalVista Pharmaceuticals, Ltd.

(Nasdaq: KALV) announced a licensing agreement with Kaken Pharmaceuticals, Co., Ltd. (JPX: 4521.



T)...

You must be a Standard 1 Year member to access this content..